Vasomedical takes EECP (enhanced external counterpulsation system) to Pakistan:
This article was originally published in Clinica
Vasomedical is introducing its enhanced external counterpulsation system (EECP) to Pakistan for the first time, with a multi-year agreement with the Pakistan Central Welfare Association. The $1.3 million deal is for the sale of 14 EECP systems and represents the Westbury, New York company's largest single order to date. Vasomedical says its technology has enormous potential in the developing world, as it is a cost-effictive and non-invasive procedure for managing symptomatic patients with cardiovascular disease on an outpatient basis.